BariPrehab: The Effect of Exercise in Patients Awaiting Bariatric Surgery
Study Details
Study Description
Brief Summary
The aim of this project is to understand the impact of a four week preoperative exercise programme on fitness and metabolic rate and weight before surgery and weight after surgery.
A single-site randomised trial at UCLH, recruiting patients awaiting bariatric surgery for obesity at UCLH, Whittington Health NHS Trust, or Homerton University Hospital NHS Foundation Trust.
The investigators will measure fitness, metabolic rate, body weight/composition and grip strength in all participants, before and after a four-week supervised physical activity intervention. The investigators will follow each participant's journey through surgery and determine whether the exercise intervention led to differences between the weight of the two groups after surgery. The investigators will also interview participants about their participation in the study in regard to the planning of future studies.
Participants randomised to the intervention group will participate in 7 physiologist-led exercise sessions online and also be instructed to complete seven self-led 30-minute home-based exercise sessions over the four-week intervention period. This equates to a total of 14 exercise sessions across the four-week (28 day) intervention.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The aim of this project is to understand the impact of a structured personalised 4-week exercise programme on resting fitness and metabolic rate in patients awaiting bariatric surgery for obesity. The hypothesis is that patients awaiting bariatric surgery who undertake a preoperative exercise programme will experience attenuated changes in functional capacity and metabolic rate compared with usual care (no exercise programme) along with alterations in autonomic control and medium-term postoperative weight loss.
The investigators propose a randomised controlled trial that will recruit 70 patients with obesity scheduled for bariatric surgery at UCLH, Whittington Health NHS Trust, and Homerton University Hospital NHS Foundation Trust. Participants will be randomly assigned to either usual care (exercise advice only) or combination exercise intervention group, during a four-week lead up to surgery, on a 1:1 basis.
The investigators will measure physical fitness, metabolic rate, and how the heart responds to hormonal changes (the sympathetic nervous system) in all participants, before and after the four-week study period. The investigators will also follow each participant's journey through surgery and determine whether the exercise intervention led to differences between the two groups after surgery in terms of weight loss. The investigators will also interview participants about their participation in the study in regard to the planning of future studies.
Baseline data collection will occur approximately six weeks prior to surgery as detailed below. Both groups will be invited to attend follow-up assessment at 4 weeks where they will undergo the same series of tests. Post-surgery, at 12 weeks and 24 weeks, participants will be invited to attend follow-up assessment where body weight will be measured. The post-operative testing visits will be aligned with scheduled hospital follow-up appointments. The total duration of participation will be approximately 32 weeks (six weeks preoperatively to six months (26 weeks) postoperatively).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Online exercise intervention A four-week preoperative physical activity intervention, involving a combination of supervised and unsupervised (live or pre-recorded), online exercise sessions. These sessions will be designed to meet the National physical activity guidelines (2020) of at least 150 minutes of low-moderate or 75 minutes of vigorous physical activity per week (or a combination of the two). The intervention will involve moderate intensity activities that aim to increase or maintain muscle strength (resistance training) as well as short bouts of vigorous aerobic exercise, using major muscle groups in the lower and upper body. |
Behavioral: Online exercise intervention
Described in arm descriptions
|
No Intervention: Control Usual care |
Outcome Measures
Primary Outcome Measures
- Fitness (VO2 in ml/kg/min) [4 weeks]
VO2 (at anaerobic threshold (AT) and peak exercise) using gas-analysed cardiopulmonary exercise testing.
Secondary Outcome Measures
- Resting metabolic rate (VO2 in ml/kg/min) [4 weeks]
Energy expenditure at rest, collected using respiratory gas-analysis via metabolic cart.
- Maximal grip strength (kg) [4 weeks]
Hand grip dynamometry, best of three repeat measures on each hand (left and right)
- Body mass (kg) [6-months post-operatively]
Body mass in kilograms using body weight scales.
- Autonomic control (heart-rate variability) [4 weeks]
Heart-rate variability measured via electrocardiogram (ECG), assessing the variability between heart beats
- Satisfaction assessed by visual analogue scale (VAS) [6-months post-operative]
Participants satisfaction on the mode of delivery and content of the programme using patient satisfaction VAS
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Adults, aged 18 and above.
-
Patients enrolled in the UCLH, Homerton or Whittington Hospitals bariatric surgery program with BMI > 30 kg/m2
-
≤5 % variation in body weight over preceding 3 months.
-
Willing and able to comply with the trial protocol.
-
Willing and able to provide written informed consent
-
Male or Female
Exclusion Criteria:
-
Pregnant or lactating mothers.
-
Weight over 180 kg (due to weight restrictions of equipment used).
-
Current use of betablockade.
-
Obstructive sleep apnoea requiring home ventilation assistance.
-
Hypo/hyperthyroidism.
-
Concurrent participation in other clinical intervention trial.
-
Clinically significant medical co-morbidities (e.g. uncontrolled hypertension, unstable cardiovascular disease) that could place at risk of an adverse response to exercise.
-
History of atrial fibrillation, unstable angina, acute coronary syndrome, congestive heart failure New York Heart Association class III-IV within the preceding 12 months.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University College London | London | United Kingdom | wC1E6BT |
Sponsors and Collaborators
- University College, London
Investigators
- Principal Investigator: Belinda Durey, UCL and UniSA
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 130811
- 273319
- 21/EM/0230